Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px

Product › Details

Alfospas®

	Next higher product group	tiropramid (INN) (qm)
	Status	1990-01-01 registration start
	Organisation	Rottapharm S.p.A.
	Today	Meda Pharma S.p.A.
	Group	Viatris (Group)

Record changed: 2023-07-10

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for pharmaceutical

[1] NeoSphere Biotechnologies GmbH. (5/14/24). "Press Release: NeoSphere Biotechnologies Partners with Kymera Therapeutics for Novel Molecular Glue Target Discovery". Martinsried....
[2] Sanofi S.A.. (5/13/24). "Press Release: Sanofi Adds over €1 Billion for Biomanufacturing to €2.5 Billion Already Committed in Major Projects in France to Support Health Sovereignty". Paris....
[3] AC Immune S.A.. (5/13/24). "Press Release: AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease". Osaka, Cambride, MA & Lausanne....
[4] H. Lundbeck A/S. (5/13/24). "Press Release: Maria Alfaiate Appointed New Executive Vice President Commercial and Corporate Strategy at Lundbeck"....
[5] iTeos Therapeutics Inc.. (5/10/24). "Press Release: iTeos Therapeutics Announces $120 Million Registered Direct Offering". Watertown, MY & Gosselies....
[6] Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren....
[7] BioVersys AG. (5/7/24). "Press Release: BioVersys Announces Expansion of Strategic Collaboration with GSK and Extension of its Series C Round by CHF 12.3 Million". Basel....
[8] Wacker Chemie AG. (5/6/24). "Press Release: Wacker Expands Production Capacity for Biopharmaceuticals in San Diego". Munich & San Diego, CA....
[9] Eisbach Bio GmbH. (5/6/24). "Press Release: Eisbach Bio Announces FDA Clearance of IND Application for EIS-12656, a First-in-Class Allosteric Inhibitor of ALC1". Martinsried....
[10] ADC Therapeutics S.A.. (5/6/24). "Press Release: ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants". Lausanne....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]